Arkema confirmed that it is in a detailed investment review, with its partner Novus International, to double production capacities at Arkema’s Beaumont Thiochemicals site in the United States.
Colombes/USA — According to the company, this project will support the strong global growth in the animal nutrition market and supply high value-added sulfur derivatives for the new methionine hydroxy analogue production unit announced by Novus at the end of 2017. The company expects the annual growth of methionine to reach 6 % over the coming years.
Subject to a final decision on this investment, expected to be made at the end of 2018, the new units should come on stream by the summer of 2021. This project is part of the French manufacturer's long-term ambition announced at its 2017 Capital Markets Day.